Apyx Medical Corporation APYX Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apyx Medical Corporation's additional paid-in capital?
- Apyx Medical Corporation (APYX) reported additional paid-in capital of $104.02M in Q1 2026.
- How has Apyx Medical Corporation's additional paid-in capital changed year-over-year?
- Apyx Medical Corporation's additional paid-in capital increased by 12.4% year-over-year, from $92.53M to $104.02M.
- What is the long-term trend for Apyx Medical Corporation's additional paid-in capital?
- Over 5 years (2020 to 2025), Apyx Medical Corporation's additional paid-in capital has grown at a 11.2% compound annual growth rate (CAGR), from $61.07M to $103.62M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.